LEAP THERAPEUTICS, INC.

Leap Therapeutics was founded on the principle that investing in great science and targeted research will rapidly translate molecules into high impact therapeutics.Our pipeline is built upon identifying, acquiring, and developing translational-stage molecules in the areas of cell signaling and immuno-oncology. Led by a proven management team, Leap Therapeutics is dedicated to building and developing a pipeline of therapeutics that has the potential to change the practice of cancer medicine.

Bank Name LEAP THERAPEUTICS, INC.
Stock Exchange NASDAQ
Symbol LPTX
Sector Healthcare
Industry Biotechnology: Biological Products
Country United States
World Region Amarica
Chairman Dr. Christopher K. Mirabelli Ph.D.
CEO Dr. Christopher K. Mirabelli Ph.D.
Employees 20
Website www.leaptx.com
Registered Year 2011

UpdateContent
UpdateContent
UpdateContent